$0.343
+0.018 (+5.19%)Al cierre
- Máximo
- 0.355
- Apertura
- 0.339
- Precio medio ponderado por volumen
- 0.34
- Volumen
- 1.08M
- Capitalización
- —
- Mínimo
- 0.315
- Importe
- 363.98K
- EV/EBITDA, TTM
- -0.03
Streamex Corp., formerly BioSig Technologies, Inc., is a real world asset (RWA) tokenization company. The Company with institutional grade infrastructure brings the gold and commodities market on chain, enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. The Company is a wholly owned subsidiary of BioSig Technologies, Inc.
Análisis de IA of Streamex Corp (STEX)
VenderStreamex Corp is not a good buy right now due to its significant financial losses and poor price performance. The current price is $0.3729, down 88.01% year-to-date, and the company reported a net loss of $14.55 million in Q2 2026. Additionally, the RSI is at 33.91, indicating oversold conditions, but the overall financial health remains concerning.
Métricas de valoración
Cronología de eventos
Noticias
9.511-02NewsfilterStreamex to Release Q3 Financial Results on November 12, 2026
- 8.510-19Newsfilter
Streamex Announces Seventh Yield Distribution for GLDY Token
- 8.510-12Newsfilter
Streamex Launches GLDY Asset Custody Service
- 5.009-01Newsfilter
Streamex Appoints New Head of Investor Relations
- 8.508-19Newsfilter
Streamex Announces Fifth Yield Distribution for GLDY Asset
Preguntas frecuentes sobre STEX, respondidas por Alphio AI
Streamex Corp., formerly BioSig Technologies, Inc., is a real world asset (RWA) tokenization company. The Company with institutional grade infrastructure brings the gold and commodities market on chain, enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. The Company is a wholly owned subsidiary of BioSig Technologies, Inc. It operates in the Financials sector.
Streamex Corp is not a good buy right now due to its significant financial losses and poor price performance. The current price is $0.3729, down 88.01% year-to-date, and the company reported a net loss of $14.55 million in Q2 2026. Additionally, the RSI is at 33.91, indicating oversold conditions, but the overall financial health remains concerning.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarArtículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.